DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 2	2026-08-06		NCT06176261

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daiichi Sankyo	144
Nancy Lin, MD	1

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana-Farber Cancer Institute	Boston	United States	626
Duke University Medical Center	Durham	United States	505
Miami Baptist Cancer Institute/	Miami	United States	1

Clinical trials